Abstract
One of Kalorama' s best-selling market research reports, this report provides
the reader with a complete analysis of the domestic and international markets
for pharmaceuticals to treat skin diseases and disorders. This edition of
Worldwide Market for Prescription Dermatological Drugs is the sixth time
Kalorama Information has comprehensively studied the dermatology markets.
Kalorama has completely re-evaluated the market from the ground up, and in
addition to the usual primary research (interviews) of industry participants,
clinicians, and regulators, we also conducted scores of interviews with users
of Kalorama' s 2004 and 2006 dermatological studies to ensure that the current
report contains the best possible data and the most useful analysis.
In this new edition, various shifts in the market are noted. There is
information on bilogics, discussion of fillers and of treatments for skin
infections such as MRSA. New companies have been added and consolidations in
the industry have been addressed.
Market information is available for the years 2004 to 2011, with the focus
year 2006 for competitive analysis. Overview and product descriptions of
general therapy segments are covered, including prescription drugs to treat:
- Acne and Rosacea
- Antiaging and Photodamage
- Dermatitis and Seborrhea
- Fungal Infections
- Hair Loss and Hair Removal
- Hyperpigmentation/Melasma
- Psoriasis
- Skin Cancer, and
- Other Skin Disorders
Other data points include competitive market share, demographics,
epidemiology, and geographic break down, which provide revenues for four
regions:
- United States
- Europe
- Japan
- Rest of world
The study covers issues and trends affecting the market, research and
developments, and more. In particular, the study explores the current and
potential effects of the aging baby boomers on the prescription dermatology
market and the continued demand for lifestyle drugs. Profiles of major market
participants are included, including:
- Allergan Inc.
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bayer AG
- Bradley Pharmaceuticals, Inc
- Bristol-Myers Squibb
- CollaGenex Pharmaceuticals
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological,
Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Nycomed Inc.
- Pfizer, Inc.
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- Sinclair Pharma Plc.
- SkinMedica
- Stiefel Laboratories, Inc.
- Valeant Pharmaceuticals, Inc.
| 
View Cart
